What is Driving the Growth of the Rheumatoid Arthritis Therapeutics Market? The rheumatoid arthritis therapeutics market is experiencing strong growth due to the rising prevalence of autoimmune diseases, advancements in biologics, and increasing demand for targeted therapies. Valued at USD 29.50 billion in 2024, the market is projected to grow at a CAGR of 4.60%, reaching USD 46.25 billion by...